Spotlight Stock This Analyst Has Bad Things to Say About Canopy Growth by Sophia Vida September 19, 2019 According to an Oppenheimer analyst, Canopy Growth is not a stock to buy. While the Canadian marijuana producer has a lot of money, at $28 a share it is still expensive says analyst Rupesh Parikh. According to Parikh, the co...